Distigmin Non-Exclusive Rebate Agreement

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline Oct 31, 2026 · 66 days left·Open·Supplies·Framework

Registrieren zum Speichern Open documents

Structured notice only

Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Distigmin (ATC-Code nach WHO: N07AA03)

40/100

Opportunity Score

Needs reviewLow complexity

SuppliesFrameworkOpen

Warum diese Bewertung?

Chance

40 / 100

Komplexität

15 / 100

Risikofaktoren

Quantities are unknown and dependent on prescription behavior and patient numbers. No minimum volumes guaranteed.

The buyer may terminate the open-house procedure if exclusive agreements are concluded, typically 8-12 months after pub...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Überblick

Moderate opportunity

Wichtige Fakten

Framework procurement
Supplies contract
1 lot
Duration until Oct 2026
Supply of pharmaceutical products containing the active substance Distigmin (ATC N07AA03).
Non-exclusive rebate agreement under §130a Abs. 8 SGB V.

Vollständige Zusammenfassung anzeigen

This is an open-house model (non-competitive) for non-exclusive pharmaceutical rebate agreements under §130a Abs.8 SGB V for the active substance Distigmin (ATC N07AA03). The buyer is AOK PLUS, covering Saxony and Thuringia. No estimated value is provided; quantities are unknown and no minimum volumes are guaranteed. The agreement runs until 31 October 2026. Participation is open to any pharmaceutical manufacturer meeting the conditions, with rolling submission deadlines. This is not a typical public procurement but a voluntary transparency notice.

Risiken

Quantities are unknown and dependent on prescription behavior and patient numbers. No minimum volumes guaranteed.

The buyer may terminate the open-house procedure if exclusive agreements are concluded, typically 8-12 months after pub...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

Pharmaceutical manufacturer as defined in §4 Abs.18 AMG.
Company must have its seat in Germany, EU, or EEA (§9 Abs.2 AMG).
No minimum volume or exclusivity; quantities are demand-driven.

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No award criteria; participation is open to all eligible manufacturers.

Auftraggeber

Name

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

Ort

Erfurt, DEU

E-Mail

[email protected]

Website

www.aok.de/pk/plus/

Auftraggeberprofil

Profil öffnen

Kennung

DE256878834

Tätigkeit

Health

Lose (1)

LOT-0001